Effectiveness of bosentan in a case of pulmonary arterial hypertension associated with myelodysplastic syndrome.
Department of Internal Medicine, Hospital San Juan de la Cruz, C/Picasso no. 2A, 2D, Úbeda, Spain, 23400, agalo1980@hotmail.com.
Antonio Luis
AL
Gámez-López
Juan Luis
JL
Bonilla-Palomas
Mirian
M
Moreno-Conde
María Cristina
MC
López-Ibáñez
Antonia
A
Villar-Ráez
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D004334:Drug Administration Schedule; D065627:Familial Primary Pulmonary Hypertension; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D013449:Sulfonamides; D000077300:Bosentan